KoBioLabs (348150) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KoBioLabs (348150) reported revenue of 69.3 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202569.3 billion KRW-9.7 billion KRW-7.0 billion KRW[source]
202468.4 billion KRW-6.9 billion KRW-4.6 billion KRW[source]
202333.1 billion KRW-18.5 billion KRW-15.2 billion KRW[source]
202211.6 billion KRW-20.3 billion KRW-23.4 billion KRW[source]
20212.9 billion KRW-16.3 billion KRW-15.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202571.5 billion KRW12.8 billion KRW58.7 billion KRW[source]
202479.0 billion KRW13.9 billion KRW65.1 billion KRW[source]
202396.9 billion KRW24.9 billion KRW72.0 billion KRW[source]
2022108.7 billion KRW23.8 billion KRW84.9 billion KRW[source]
2021100.2 billion KRW12.9 billion KRW87.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice